News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,333 Results
Type
Article (52652)
Company Profile (356)
Press Release (699313)
Multimedia
Podcasts (106)
Webinars (19)
Section
Business (209561)
Career Advice (2057)
Deals (36177)
Drug Delivery (124)
Drug Development (84910)
Employer Resources (174)
FDA (16882)
Job Trends (15254)
News (355979)
Policy (33755)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2750)
Academic (1)
Accelerated approval (41)
Adcomms (31)
Allergies (152)
Alliances (51405)
ALS (182)
Alzheimer's disease (1696)
Antibody-drug conjugate (ADC) (369)
Approvals (17134)
Artificial intelligence (574)
Autoimmune disease (178)
Automation (45)
Bankruptcy (370)
Best Places to Work (11860)
BIOSECURE Act (22)
Biosimilars (196)
Biotechnology (246)
Bladder cancer (176)
Brain cancer (67)
Breast cancer (695)
Cancer (5312)
Cardiovascular disease (424)
Career advice (1738)
Career pathing (37)
CAR-T (304)
CDC (53)
Celiac Disease (2)
Cell therapy (803)
Cervical cancer (40)
Clinical research (72408)
Collaboration (1849)
Company closure (4)
Compensation (1208)
Complete response letters (70)
COVID-19 (2773)
CRISPR (107)
C-suite (928)
Cystic fibrosis (149)
Data (6587)
Decentralized trials (2)
Denatured (30)
Depression (139)
Diabetes (516)
Diagnostics (7041)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (276)
Drug pricing (197)
Drug shortages (28)
Duchenne muscular dystrophy (243)
Earnings (91633)
Editorial (60)
Employer branding (21)
Employer resources (153)
Events (121581)
Executive appointments (1017)
FDA (20147)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1552)
Gene editing (225)
Generative AI (48)
Gene therapy (658)
GLP-1 (1006)
Government (4808)
Grass and pollen (7)
Guidances (385)
Healthcare (19423)
HIV (71)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (270)
Immuno-oncology (74)
Indications (133)
Infectious disease (3060)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (124)
Intellectual property (261)
Interviews (321)
IPO (16922)
IRA (51)
Job creations (3745)
Job search strategy (1454)
JPM (64)
Kidney cancer (19)
Labor market (87)
Layoffs (586)
Leadership (33)
Legal (8188)
Liver cancer (102)
Longevity (17)
Lung cancer (717)
Lymphoma (392)
Machine learning (46)
Management (59)
Manufacturing (843)
MASH (171)
Medical device (13915)
Medtech (13978)
Mergers & acquisitions (20357)
Metabolic disorders (1323)
mRNA (184)
Multiple sclerosis (170)
NASH (16)
Neurodegenerative disease (339)
Neuropsychiatric disorders (92)
Neuroscience (2999)
Neurotech (1)
NextGen: Class of 2026 (6754)
Non-profit (4698)
Now hiring (69)
Obesity (624)
Opinion (288)
Ovarian cancer (175)
Pain (214)
Pancreatic cancer (252)
Parkinson's disease (294)
Partnered (33)
Patents (526)
Patient recruitment (540)
Peanut (60)
People (60465)
Pharmaceutical (70)
Pharmacy benefit managers (30)
Phase 1 (22672)
Phase 2 (31731)
Phase 3 (23700)
Pipeline (5986)
Policy (306)
Postmarket research (2815)
Preclinical (9787)
Press Release (67)
Prostate cancer (273)
Psychedelics (51)
Radiopharmaceuticals (311)
Rare diseases (949)
Real estate (6119)
Recruiting (70)
Regulatory (25460)
Reports (53)
Research institute (2570)
Resumes & cover letters (356)
Rett syndrome (30)
RNA editing (19)
RSV (82)
Schizophrenia (151)
Series A (259)
Series B (198)
Service/supplier (12)
Sickle cell disease (108)
Special edition (24)
Spinal muscular atrophy (169)
Sponsored (44)
Startups (3792)
State (2)
Stomach cancer (21)
Supply chain (106)
Tariffs (87)
The Weekly (74)
Vaccines (1066)
Venture capital (94)
Weight loss (403)
Women's health (99)
Worklife (19)
Date
Today (162)
Last 7 days (874)
Last 30 days (3035)
Last 365 days (30797)
2026 (5319)
2025 (30923)
2024 (36104)
2023 (40959)
2022 (52222)
2021 (56782)
2020 (55088)
2019 (47720)
2018 (35971)
2017 (33331)
2016 (32835)
2015 (38838)
2014 (32633)
2013 (28046)
2012 (30314)
2011 (30854)
2010 (29172)
Location
Africa (787)
Alabama (86)
Alaska (7)
Arizona (323)
Arkansas (13)
Asia (41683)
Australia (7002)
California (11852)
Canada (3390)
China (1165)
Colorado (496)
Connecticut (506)
Delaware (344)
Europe (92405)
Florida (1768)
Georgia (375)
Hawaii (3)
Idaho (62)
Illinois (911)
India (72)
Indiana (543)
Iowa (23)
Japan (457)
Kansas (130)
Kentucky (44)
Louisiana (30)
Maine (72)
Maryland (1455)
Massachusetts (8524)
Michigan (339)
Minnesota (649)
Mississippi (6)
Missouri (133)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (81)
New Jersey (3147)
New Mexico (30)
New York (3123)
North Carolina (1528)
North Dakota (9)
Northern California (5804)
Ohio (352)
Oklahoma (21)
Oregon (45)
Pennsylvania (2391)
Puerto Rico (24)
Rhode Island (49)
South America (1162)
South Carolina (69)
South Dakota (1)
Southern California (4613)
Tennessee (187)
Texas (1820)
United States (42030)
Utah (355)
Vermont (1)
Virginia (273)
Washington D.C. (81)
Washington State (969)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
752,333 Results for "cancer genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MiraDx Launches New Genetic Test Expanding Radiation Therapy Risk Assessment for Prostate Cancer Patients
February 25, 2026
·
4 min read
Press Releases
Prostate Cancer Foundation Launches Guide on Genetic Testing for Patients With Advanced Prostate Cancer
November 21, 2025
·
5 min read
Press Releases
/C O R R E C T I O N -- BLOOD CANCER UNITED, INC./
February 17, 2026
·
3 min read
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
Solstice Oncology will gain an exclusive worldwide license to Harbour BioMed’s porustobrt, an anti-CTLA-4 antibody currently being studied for melanoma, colorectal cancer and other malignancies in China.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
In a Phase 1 study, 82% of patients on VIR-5500 achieved at least a 50% reduction in PSA levels—a result analysts praised as competitive in the prostate cancer space.
February 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
New Research: Rectal Cancer Incidence Rising After Decades of Decline as Colorectal Cancer Shifts Toward Younger Generations
March 2, 2026
·
5 min read
Press Releases
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
February 19, 2026
·
13 min read
Press Releases
CNIO Awarded Three-Year Grant to Advance MeCo Score in Breast Cancer
€320K grant awarded to internationally ranked top-10 cancer institute supports expansion of MeCo Diagnostics’ predictive biomarker guiding antifibrotic therapy
February 27, 2026
·
1 min read
Press Releases
PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
February 5, 2026
·
4 min read
1 of 75,234
Next
